Results 241 to 250 of about 951,451 (326)
Abstract Background Huntington's disease (HD) is characterized by early, selective, progressive vulnerability of striatal medium spiny neurons (MSNs). Proenkephalin (PENK), a precursor of opioid peptides abundantly expressed in MSNs, is a promising biomarker of striatal integrity, but region‐specific associations and its potential for early‐stage ...
Mena Farag +14 more
wiley +1 more source
Contrast analysis for competing hypotheses: A tutorial using the R package cofad. [PDF]
Henninger M, Malejka S, Titz J.
europepmc +1 more source
Covariate adjustment, factorial designs and clustered data in diagnostic accuracy studies
Weber, Philipp +3 more
openalex +1 more source
Abstract Background Friedreich's ataxia is a rare, neurodegenerative, multisystem disorder. While ataxia is a hallmark, non‐ataxia signs, including muscle weakness, spasticity, and dysphagia are equally disabling. The Inventory of Non‐Ataxia Signs (INAS) is a symptom list transformable to a 16‐item count.
Stella Andrea Lischewski +23 more
wiley +1 more source
Production of <i>Dichostereum sordulentum</i> Laccase and Its Entrapment in Lignocellulosic Biopolymers for Estrogen Biodegradation. [PDF]
Vázquez V +10 more
europepmc +1 more source
The impact of recent approvals on future alzheimer's disease clinical development: Statistical considerations for combination trials. [PDF]
Dickson SP +6 more
europepmc +1 more source
Optimal hierarchial factorial designs : the multiple design multiresponse case with cost constraint
Samuel V. Givens
openalex +1 more source
This review highlights recent advancements in Severe Plastic Deformation (SPD) techniques tailored for tubular samples. The mechanisms of processing are critically discussed with emphasis on microstructural control and the governing process parameters that enable refinement to ultrafine‐ and nano‐grained structures. Comparative insights into equivalent
Eman M. Zayed +5 more
wiley +1 more source
ABSTRACT This paper examines the impacts of Volume‐Based Procurement (VBP) policies on pharmaceutical supply chains, with a focus on the strategic behaviors of manufacturers. VBP aims to reduce costs and stabilize supplies by centralizing procurement through competition based on volumes and prices.
Nani Zhou, Tong Wang, Guohua Wan
wiley +1 more source
MASHt: Software for statistical analysis of transcriptomes' qualitative features in factorial experiments. [PDF]
Nuc M +4 more
europepmc +1 more source

